Copertina

Basic concepts of metabolic flux analysis

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	Claudia Patricia Sánchez Henao
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Universidad del Valle 2021
Soggetti:	Ingeniería Metabolic modeling Flux balance analysis Metabolic flux analysis Metabolic control analysis
Accesso online:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Metabolic Analysis of Escherichia coli in the Presence and Absence of the Carboxylating Enzymes Phosphoenolpyruvate Carboxylase and Pyruvate Carboxylase
di: Gokarn R.R., † Eiteman M. A. and Altman E
Pubblicazione: (2000)

Influence of the physiological state on the energy, protein and endocrine metabolism, in Siboney de Cuba cows
di: C. Gallego
Pubblicazione: (2017)

Risk factors associated with the metabolic syndrome in Cali, Colombia (2013): Acase-control study
di: Sayda Milena Pico
Pubblicazione: (2019)

Influence of the physiological state on the energy, protein and endocrine metabolism, in Siboney de Cuba cows
di: C. Gallego
Pubblicazione: (2017)

Anthropometric metabolic subtypes and health outcomes: A data‐driven cluster analysis
di: Li Ding, et al.
Pubblicazione: (2025)

In vivo mapping of postprandial hepatic glucose metabolism using dynamic magnetic resonance spectroscopy combined with stable isotope flux analysis in Roux‐en‐Y gastric bypass adults and non‐operated controls: A case–control study
di: Simone Poli, et al.
Pubblicazione: (2024)

Non-universal interspecific allometric scaling of metabolism
di: Jafferson K. L. da Silva
Pubblicazione: (2009)

Chronic intermittent hypoxia modulates energy metabolic pathways and improves hypoxia tolerance capacity in golden pompano, Trachinotus blochii.
di: Fang, Geng Hui, et al.
Pubblicazione: (2025)

Non‐invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta‐analysis
di: Meng‐Di Chen, et al.
Pubblicazione: (2024)

The effects of antihypertensive drugs on glucose metabolism
di: Zhe Li, et al.
Pubblicazione: (2024)

The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials
di: Rachelle Haber, et al.
Pubblicazione: (2024)

Impact of bariatric surgery on glycaemic and metabolic outcomes in people with obesity and type 2 diabetes mellitus: A meta‐analysis
di: Xu Han, et al.
Pubblicazione: (2025)

Lifestyle and quality of life in patients with metabolic syndrome and type 2 diabetes
di: Yenny Alexandra Granados-Vidal
Pubblicazione: (2019)

The prognostic value of metabolic dysfunction‐associated steatotic liver disease in acute myocardial infarction: A propensity score‐matched analysis
di: Gwyneth Kong, et al.
Pubblicazione: (2024)

Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials
di: João Pedro Ferreira, et al.
Pubblicazione: (2025)

ACAD10 is not required for metformin's metabolic actions or for maintenance of whole‐body metabolism in C57BL / 6J mice
di: Michael J. Yew, et al.
Pubblicazione: (2024)

Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
di: Claudio Maffeis, et al.
Pubblicazione: (2024)

Swimming respirometry provides insights into the physiological energetics of juvenile Atlantic bluefin tuna Thunnus thynnus.
di: McKenzie, David J, et al.
Pubblicazione: (2026)

Metformin attenuates metabolic insulin sensitivity and insulin‐stimulated carbohydrate oxidation after high‐intensity exercise training in adults at risk for metabolic syndrome
di: Steven K. Malin, et al.
Pubblicazione: (2026)

Genotype‐guided dual antiplatelet therapy in minor stroke or transient ischemic attack with metabolic syndrome: A post hoc analysis of CHANCE ‐2
di: Zhiyuan Feng, et al.
Pubblicazione: (2025)

Metformin continuation post‐metabolic bariatric surgery and relapse of diabetes
di: Dror Dicker, et al.
Pubblicazione: (2024)

Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes
di: Michelle D. Lundholm, et al.
Pubblicazione: (2024)

Cannabidiol improves metabolic profiles and alleviates liver inflammation and fibrosis in conditions of androgenic obesity and polycystic ovary syndrome
di: Francisco J. Ponce‐Díaz, et al.
Pubblicazione: (2025)

Worldwide burden of metabolic risk‐related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
di: Xinjiang Dong, et al.
Pubblicazione: (2025)

Efficacy of a low‐carbohydrate diet combined with exercise on glycemic control and metabolic health in type 2 diabetes mellitus: A systematic review and meta‐analysis
di: Ye He, et al.
Pubblicazione: (2025)

Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis
di: Gong Feng, et al.
Pubblicazione: (2024)

The effects of anti‐obesity medications on bone metabolism: A critical appraisal
di: Athanasios D. Anastasilakis, et al.
Pubblicazione: (2025)

Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases
di: Hao Hong, et al.
Pubblicazione: (2024)

Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction
di: Jeremy W. Tomlinson
Pubblicazione: (2024)

Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
di: Stergios A. Polyzos, et al.
Pubblicazione: (2026)

Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis: Results from an exploratory, randomized, placebo‐controlled, crossover study
di: Valeria Gutierrez de Piñeres, et al.
Pubblicazione: (2025)

A metabolic comparison of GIPR agonism versus GIPR antagonism in male mice
di: Iona Davies, et al.
Pubblicazione: (2025)

GLP ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
di: Tommaso Bucci, et al.
Pubblicazione: (2025)

Biomarkers for cardiovascular–kidney metabolic syndrome: Clinical utility in diagnosis, screening, and treatment
di: Kevin Yau, et al.
Pubblicazione: (2025)

Comparative efficacy and safety of pharmacologic therapies for metabolic dysfunction‐associated steatotic liver disease over 24 weeks in reducing liver steatosis and fibrosis: A network meta‐analysis
di: Jiaxin Zhong, et al.
Pubblicazione: (2025)

Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept
di: Shobha Bhattachar, et al.
Pubblicazione: (2026)

Diagnostic accuracy of Agile‐4 score for liver cirrhosis in patients with metabolic dysfunction‐associated steatotic liver disease. A systematic review and meta‐analysis of diagnostic test accuracy studies
di: Konstantinos Malandris, et al.
Pubblicazione: (2024)

Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials
di: Matthew J. Armstrong, et al.
Pubblicazione: (2024)

Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity
di: Jonathan Brix Winther, et al.
Pubblicazione: (2024)

ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
di: Sara Russo, et al.
Pubblicazione: (2025)